Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Link opens in a new tab
Search content at Aston Research Explorer
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Management of type 2 diabetes: new and future developments in treatment
Abd A. Tahrani
,
Clifford J Bailey
, Stefano Del Prato
, Anthony H. Barnett
School of Biosciences
Aston Research Centre for Health in Ageing
College of Health and Life Sciences
University College Birmingham
Università di Pisa
Birmingham Heartlands Hospital
Research output
:
Contribution to journal
›
Article
›
peer-review
506
Link opens in a new tab
Citations (SciVal)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of type 2 diabetes: new and future developments in treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Liver
100%
Insulin Action
100%
Glycemic Control
100%
A1 Receptor
100%
Insulin Release
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Incretin Hormones
100%
Glucagon-like
100%
Insulin Secretion
100%
Glucagon
100%
Hepatic Glucose Production
100%
Receptor Agonist
100%
Natural History
100%
Satiety
100%
Dipeptidyl peptidase-4 (DPP-4)
100%
Postprandial Insulin
100%
Type 2 Diabetes Complications
100%
Fatty Acid Receptor
100%
Glucocorticoid-induced
100%
Hydroxysteroid Dehydrogenase
100%
Metabolic Inhibitors
100%
Glucokinase Activator
100%
Bariatric Surgery
100%
Once-weekly
100%
New Treatment Options
100%
G Protein-coupled
100%
Sodium-glucose Cotransporter
100%
Glucagon Receptor Antagonist
100%
Renal Glucose
100%
Increasing Prevalence
100%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Receptor
50%
Glucocorticoid
50%
Incretin
50%
Dipeptidyl Peptidase IV
50%
Insulin Release
50%
Glucagon Like Peptide 1 Receptor
50%
Prevalence
50%
Glycemic
50%
Glucokinase
50%
Fatty Acid
50%
Guanine Nucleotide Binding Protein
50%
Hydroxysteroid Dehydrogenase
50%
Bariatric Surgery
50%
Glucagon Receptor Antagonist
50%
Glucagon
50%
Satiety
50%
Sodium Glucose Cotransporter 2
50%
Pharmacology, Toxicology and Pharmaceutical Science
Maturity Onset Diabetes of the Young
100%
Prevalence
50%
Glucocorticoid
50%
Dipeptidyl Peptidase IV
50%
Incretin
50%
Fatty Acid
50%
Guanine Nucleotide Binding Protein
50%
Glucagon-Like Peptide 1 Receptor
50%
Glucagon
50%
Receptor Agonist
50%
Elimination
50%
Hydroxysteroid Dehydrogenase
50%
Glucokinase
50%
Sodium Glucose Cotransporter 2
50%
Glucagon Receptor Antagonist
50%